Featured Articles

As multiple stakeholders come at the problem from different angles, sustainable global access pathways are beginning to align. From process efficiencies aimed at reining in costs to innovative manufacturing and go-to-market models, cell and... read more

To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more

To benchmark the sector’s progress in the inaugural issue of Cell & Gene Therapy Review, we asked thought leaders a single question: What is the biggest challenge facing the CGT sector in 2025? read more

As we head into a new year, it’s time to look back at 2024 and appreciate the tremendous progress made in cell and gene therapy. read more

The industry stays on track with FDA approvals for cell and gene therapies read more

By continuing to crack the code of complex manufacturing, we can move closer to making long-lasting treatments affordable and available to all read more